Citius Oncology (CTOR) Return on Equity [ROE] (2023 - 2026)
Citius Oncology (CTOR) reported Return on Equity [ROE] of -127.05% for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 26.81 percentage points from -100.24% a year earlier and down 32.04 percentage points from the prior quarter.
Powered by 
Analysis
Citius Oncology (CTOR) Return on Equity [ROE] (2023 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Citius Oncology posted Return on Equity [ROE] of -54.42%, up 7.00 percentage points from FY2024.
- Return on Equity [ROE] has a three-year change of +27.94 percentage points (FY2022 to FY2025).
- By fiscal year, Return on Equity [ROE] came in at -61.42% in FY2024, -19.59% in FY2023 (+62.77 pp) and -82.36% in FY2022.
- The fiscal Q3 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since fiscal Q2 2024.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -95.01% (Q2 2026), -45.77% (Q1 2026) and -64.10% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 4.97% |
| 10 | Citius Oncology | 103.64 Mn | 103.64 Mn | 1.00 Mn | -127.05% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -127.05% |
| Mar 31, 2026 | -95.01% |
| Dec 31, 2025 | -45.77% |
| Sep 30, 2025 | -64.10% |
| Jun 30, 2025 | -72.13% |
| Mar 31, 2025 | -62.40% |
| Dec 31, 2024 | -48.03% |
| Jun 30, 2024 | -80.03% |
| Mar 31, 2024 | -47.84% |
| Dec 31, 2023 | -22.78% |
API Access
Citius Oncology Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CTOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CTOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CTOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();